LRP4 and myasthenia gravis: MG cases that are notably absent of discernible AAbs against pivotal targets such as AChR, MuSK, or LRP4 (MG-DSN) hold allure in the scientific realm and encompass a cohort with distinct pathogenic heterogeneity.